Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Scientific Title
A Phase 1b/2, Open-label Dose Escalation With Expansion Study of GB5121 in Adult Patients With Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma or Primary Vitreoretinal Lymphoma, With a Phase 2 Open-label Single Dose Level Study of GB5121 in Adult Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma